Of note, SOX4 is a master regulator of the epithelial-mesenchymal transition (EMT) in breast cancer [20], and is associated with overexpression of LINC00340, a cis-acting element in cluster I (basal-related). This evidence concerns the gene SOX4 and breast cancer.